Literature DB >> 679171

Structure-activity study of the inhibition of microtubule assembly in vitro by podophyllotoxin and its congeners.

J D Loike, C F Brewer, H Sternlicht, W J Gensler, S B Horwitz.   

Abstract

This study investigates the inhibition of microtubule assembly in vitro by podophyllotoxin and its derivatives, which include in part the antitumor compounds 4'-demethylepipodophyllotoxin ethylidene beta-D-glucoside (VP-16-213) and 4'-demethylepipodophyllotoxin thenylidene beta-D-glucoside (VM-26); the cyclic ethers, cyclic sulfides, and cyclic sulfones of podophyllotoxin and deoxypodophyllotoxin; epipodophyllotoxin; picropodophyllotoxin; and several 4'-demethyl compounds. The inhibitory activity of these derivatives is sensitive to the configuration and size of substituents at position 4 in ring C and to steric features of substituents at position 12 in ring D. Decreasing activity correlates with the increasing size of the substituent at position 12, as indexed by their van der Waals radii. These results suggest that rings C and D of these drugs are involved in their interaction with the podophyllotoxin-binding site in tubulin.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 679171

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  20 in total

Review 1.  Antineoplastic drugs in 1990. A review (Part II).

Authors:  D J Black; R B Livingston
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

2.  Antibacterial effect of etoposide in vitro.

Authors:  W Calame; R van der Waals; N Douwes-Idema; H Mattie; R van Furth
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

3.  Modification of the pendant ring of podophyllotoxin.

Authors:  D C Ayres; C K Lim
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

4.  Pharmacokinetic study of VM26 given as a prolonged IV infusion to ovarian cancer patients.

Authors:  C Rossi; M Zucchetti; C Sessa; R Urso; C Mangioni; M D'Incalci
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

Review 5.  Etoposide and teniposide. Bioanalysis, metabolism and clinical pharmacokinetics.

Authors:  J J Holthuis
Journal:  Pharm Weekbl Sci       Date:  1988-06-17

Review 6.  VP16-213 and podophyllotoxin. A study on the relationship between chemical structure and biological activity.

Authors:  J D Loike
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

7.  Molecular modelling evaluation of the cytotoxic activity of podophyllotoxin analogues.

Authors:  Md Afroz Alam; Pradeep Kumar Naik
Journal:  J Comput Aided Mol Des       Date:  2008-12-04       Impact factor: 3.686

8.  Cutaneous cytodestructive potency of lignans. I. A comparative evaluation of influence on epidermal and dermal DNA synthesis and on dermal microcirculation in the hairless mouse.

Authors:  G von Krogh; H I Maibach
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

Review 9.  Pharmacokinetic optimisation of treatment with oral etoposide.

Authors:  Giuseppe Toffoli; Giuseppe Corona; Barbara Basso; Mauro Boiocchi
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

10.  Temperature-dependent growth and emergence of functional leaves: an adaptive mechanism in the seedlings of the western Himalayan plant Podophyllum hexandrum.

Authors:  Rekha Kushwaha; Subedar Pandey; Sanjoy Chanda; Amita Bhattacharya; Paramvir Singh Ahuja
Journal:  J Plant Res       Date:  2008-03-13       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.